Lung publishes original articles, reviews and editorials on all aspects of the healthy and diseased lungs, of the airways, and of breathing. Epidemiological, clinical, pathophysiological, biochemical, and pharmacological studies fall within the scope of the journal. Case reports, short communications and technical notes can be accepted if they are of particular interest.
Original research articles, early reports, review articles, commentaries and editorials covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are all welcome. Letters to the journals are also welcomed although authors should be aware that the majority will be published online only. Early reports should briefly describe the initial results of a research topic and will be expedited through peer-review.
Manuscripts describing studies on cell lines will only be considered if the data compares at least two types of distinct cell lines and the results have general implications on the understanding of the biology of chest tumours. Authors of studies on cell lines must also agree to make freely available to other researchers any of the cells, clones of cells, or DNA or antibodies, etc, that were used in the research reported and that are not available from commercial suppliers.
Manuscripts should be submitted online at
If you wish your article to be freely available online immediately upon publication (as some funding bodies now require), you can opt for it to be included in SAGE Choice upon payment of a publication fee. Manuscript submission and refereeing procedure is unchanged, but on acceptance of your article you will be asked to let SAGE know directly if you are choosing SAGE Choice.If funding has been provided for your research, convention dictates that you acknowledge the source and grant information in the Acknowledgements section of your article. Please note that in some cases, grant funders require authors to attribute the funding source, describe the role of the study funding body and include the relevant grant reference numbers.
lupus, systemic lupus nephritis, rheumatology
Lymphatic Research and Biology, a quarterly peer-reviewed journal, provides an interdisciplinary forum for the world's leading biomedical investigators to discuss current and anticipated developments in lymphatic biology and pathology.The Journal features fundamental scientific research of relevance to the lymphatic system. Original work emanates from a variety of investigative disciplines, including genetics, biochemistry and biophysics, cellular and molecular biology, physiology and pharmacology, anatomy, developmental biology, and pathology. The Journal also encourages the submission of state-of-the art reviews in focus areas such as vasculogenesis and angiogenesis, the genetics of lymphatic disorders, muscle cell biology, interstitial signaling mechanisms, and others.
Die MMW ist ein crossmediales medizinisches Fortbildungsorgan für niedergelassene Ärzte. Siebietet in Print und Online wissenschaftlich seriöse, kompetent und lesefreundlich aufbereitete aktuelleMedizininhalte mit hohem Praxisnutzen. Rund 50 renommierte Herausgeber garantieren die hohefachliche Qualität. Die MMW bietet 30 bis 40 CME-Fortbildungen mit über 100 000 Teilnehmern jährlich.
Machine Learning: Health is a multidisciplinary open access journal dedicated to the application of machine learning, artificial intelligence (AI) and data-driven computational methods across healthcare and the medical, biological, clinical, and health sciences. The journal also publishes research that presents methodological, theoretical, or conceptual advances in machine learning and AI with applications to medicine and health sciences.
Published four times each year (February, May, August, and November),